1 Ministry of Health and Sports. Situation Report 134 on COVID-19 in Myanmar. Report No. 134, (Department of Public Health. Central Epidemiology Unit, 2020).
2 Ministry of Health and Sports. Situating Report on COVID-19 in Myanmar. (Department of Public Health, Central Epidemiology Unit).
3 Sironi, M. et al. SARS-CoV-2 and COVID-19: A genetic, epidemiological, and evolutionary perspective. Infection, genetics and evolution : Journal of Molecular epidemiology and evolutionary genetics in infectious diseases 84, 104384-104384, doi:10.1016/j.meegid.2020.104384 (2020).
4 Yuki, K., Fujiogi, M. & Koutsogiannaki, S. COVID-19 pathophysiology: A review. Clinical immunology (Orlando, Fla.) 215, 108427-108427, doi:10.1016/j.clim.2020.108427 (2020).
5 Mercatelli, D. & Giorgi, F. M. Geographic and Genomic Distribution of SARS-CoV-2 Mutations. Frontiers in Microbiology 11, doi:10.3389/fmicb.2020.01800 (2020).
6 NA Pipelines R&D et al. COVID-19 ARTIC v3 Illumina library construction and sequencing protocol V.3. protocols.io, doi:dx.doi.org/10.17504/protocols.io.bgq3jvyn.
7 Cleemput, S. et al. Genome Detective Coronavirus Typing Tool for rapid identification and characterization of novel coronavirus genomes. bioRxiv, 2020.2001.2031.928796, doi:10.1101/2020.01.31.928796 (2020).
8 Singer, J., Gifford, R., Cotten, M. & Robertson, D. CoV-GLUE: A Web Application for Tracking SARS-CoV-2 Genomic Variation. . Preprints 2020, 2020060225, doi:doi: 10.20944/preprints202006.0225.v1.
9 Hadfield, J. et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34, 4121-4123, doi:10.1093/bioinformatics/bty407 (2018).
10 Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology. bioRxiv, 2020.2004.2017.046086, doi:10.1101/2020.04.17.046086 (2020).
11 Chong, Y. M. et al. SARS-CoV-2 lineage B.6 is the major contributor to transmission in Malaysia. bioRxiv, 2020.2008.2027.269738, doi:10.1101/2020.08.27.269738 (2020).
12 Zhao, Z. et al. Moderate mutation rate in the SARS coronavirus genome and its implications. BMC Evol. Biol. 4, 21 (2004).
13 Ortiz-Prado, E. et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn. Microbiol. Infect. Dis. 98, 115094, doi:https://doi.org/10.1016/j.diagmicrobio.2020.115094 (2020).
14 Korber, B. et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell 182, 812-827.e819, doi:https://doi.org/10.1016/j.cell.2020.06.043 (2020).
15 Zhang, L. et al. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv, 2020.2006.2012.148726, doi:10.1101/2020.06.12.148726 (2020).
16 Lal, S. K., Liu, P. & Leibowitz, J. RNA Higher-Order Structures Within the Coronavirus 5′ and 3′ Untranslated Regions and Their Roles in Viral Replication. Molecular Biology of the SARS-Coronavirus, 47-61 (2009).
17 Kim, D. et al. The Architecture of SARS-CoV-2 Transcriptome. Cell 181, 914-921.e910, doi:10.1016/j.cell.2020.04.011 (2020).
18 Prado-Vivar, B. a. B.-W., Monica and Guadalupe, Juan Jose and Marquez, Sully and Gutierrez, Bernardo and Rojas-Silva, Patricio and Grunauer, Michelle and Trueba, Gabriel and Barragan, Veronica and Cardenas, Paul, . COVID-19 Re-Infection by a Phylogenetically Distinct SARS-CoV-2 Variant, First Confirmed Event in South America SSRN, doi:http://dx.doi.org/10.2139/ssrn.3686174.
19 Yin, C. Genotyping coronavirus SARS-CoV-2: methods and implications. Genomics 112, 3588-3596, doi:https://doi.org/10.1016/j.ygeno.2020.04.016 (2020).